294 – Topical Antimicrobial Agents

[1]  N. Sharma,et al.  Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. , 2013, Ophthalmology.

[2]  S. Orlow,et al.  Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne , 2013, Pediatrics.

[3]  M. Akeroyd,et al.  Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children. , 2013, The Cochrane database of systematic reviews.

[4]  Hongyue Wang,et al.  A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children. , 2013, The Journal of pediatrics.

[5]  M. West,et al.  Current Treatment Recommendations for Topical Burn Therapy , 1990, Drugs.

[6]  A. Markham,et al.  Ofloxacin Otic Solution , 2012, Drugs.

[7]  S. Rumelt,et al.  Efficacy comparison between povidone iodine 2.5% and tetracycline 1% in prevention of ophthalmia neonatorum. , 2011, Ophthalmology.

[8]  G. Comer,et al.  Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Kirk M. Bateman,et al.  Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children. , 2011, Clinical therapeutics.

[10]  S. Saeed,et al.  Interventions for acute otitis externa. , 2010, The Cochrane database of systematic reviews.

[11]  Benjamin A Lipsky,et al.  Topical antimicrobial therapy for treating chronic wounds. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Rademaker,et al.  Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity , 2009, Pediatrics.

[13]  A. Adán,et al.  Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration. , 2009, The Journal of antimicrobial chemotherapy.

[14]  Rebecca L. Chain,et al.  HYPOCHLORITE KILLING OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS , 2008, The Pediatric infectious disease journal.

[15]  P. Roland,et al.  A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. , 2008, American journal of otolaryngology.

[16]  O. Chosidow,et al.  Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double‐blind multicentre placebo‐controlled trial , 2008, The British journal of dermatology.

[17]  C. Lemley,et al.  ENDOPHTHALMITIS: A Review of Current Evaluation and Management , 2007, Retina.

[18]  Y. Hata,et al.  Aqueous and Vitreous Penetration of Levofloxacin after Topical and/or Oral Administration , 2003, European journal of ophthalmology.

[19]  C. Gamble,et al.  Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. , 2006, The Cochrane database of systematic reviews.

[20]  S. Efem,et al.  The antimicrobial spectrum of honey and its clinical significance , 1992, Infection.

[21]  Credé.  Die Verhütung der Augenentzündung der Neugeborenen , 1881, Archiv für Gynäkologie.

[22]  Matthew A. Thomas,et al.  Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. , 2004, Transactions of the American Ophthalmological Society.

[23]  P. Roland,et al.  Microbiology of Acute Otitis Externa , 2002, The Laryngoscope.

[24]  I. Pearce,et al.  Vitreous penetration of levofloxacin in the uninflamed phakic human eye , 2002, The British journal of ophthalmology.

[25]  A. Bozkurt,et al.  Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration , 1999, Eye.

[26]  S. Baba,et al.  Antimicrobial effects of electrolytic products of sodium chloride--comparative evaluation with sodium hypochlorite solution and efficacy in handwashing. , 1998, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[27]  M. Seidlin,et al.  Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media. , 1998, Clinical therapeutics.

[28]  A. Bozkurt,et al.  PENETRATION OF OFLOXACIN IN HUMAN AQUEOUS AND VITREOUS HUMORS FOLLOWING ORAL AND TOPICAL ADMINISTRATION , 1998, Retina.

[29]  R. Jones,et al.  Ofloxacin otic solution for treatment of otitis externa in children and adults. , 1997, Archives of otolaryngology--head & neck surgery.

[30]  J. Weiss.  Current Options for the Topical Treatment of Acne Vulgaris , 1997, Pediatric dermatology.

[31]  M. Fisher,et al.  In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods. , 1997, The Journal of burn care & rehabilitation.

[32]  R. D. Gross,et al.  A Comparison of Ciprofloxacin and Tobramycin in Bacterial Conjunctivtis in Children , 1997, Clinical pediatrics.

[33]  J. Mensa,et al.  [Prospective double-blind randomized study of the efficacy and tolerance of topical ciprofloxacin vs topical gentamicin in the treatment of simple chronic otitis media and diffuse external otitis]. , 1996, Acta otorrinolaringologica espanola.

[34]  C. V. van Hasselt,et al.  A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media , 1996, The Journal of Laryngology & Otology.

[35]  C. Kauffman,et al.  Mupirocin Resistance: Clinical and Molecular Epidemiology , 1995, Infection Control & Hospital Epidemiology.

[36]  S. Isenberg,et al.  A controlled trial of povidone‐iodine as prophylaxis against ophthalmia neonatorum , 1995, The New England journal of medicine.

[37]  R. Haley,et al.  Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. , 1995, The Journal of infectious diseases.

[38]  G. Peyman,et al.  Prophylaxis of endophthalmitis. , 1994, Ophthalmic surgery.

[39]  C. Brun-Buisson,et al.  Can Topical and Nonabsorbable Antimicrobials Prevent Cross-Transmission of Resistant Strains in ICUs? , 1994, Infection Control & Hospital Epidemiology.

[40]  S. Boyce,et al.  Selection of Topical Antimicrobial Agents for Cultured Skin for Burns by Combined Assessment of Cellular Cytotoxicity and Antimicrobial Activity , 1993, Plastic and reconstructive surgery.

[41]  Nannette Nicholson,et al.  Therapeutic Management of Chronic Suppurative Otitis Media with Otic Drops , 1993, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[42]  J. Sloss,et al.  Acetic acid used for the elimination of Pseudomonas aeruginosa from burn and soft tissue wounds , 1993, Journal of the Royal Army Medical Corps.

[43]  B. Doft,et al.  Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. , 1993, Archives of ophthalmology.

[44]  M. Hazen,et al.  Honey for wounds, ulcers, and skin graft preservation , 1993, The Lancet.

[45]  W. Dibb,et al.  Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment. , 1993, Current medical research and opinion.

[46]  M. Subrahmanyam.  Honey impregnated gauze versus polyurethane film (OpSite) in the treatment of burns--a prospective randomised study. , 1993, British journal of plastic surgery.

[47]  Stephen Milner.  Acetic acid to treat Pseudomonas aeruginosa in superficial wounds and burns , 1992, The Lancet.

[48]  A. Agius,et al.  A prospective study of otitis externa. , 1992, Clinical otolaryngology and allied sciences.

[49]  J. Rey-Calero,et al.  Evaluation of the penetration strength, bactericidal efficacy and spectrum of action of several antimicrobial creams against isolated microorganisms in a burn centre. , 1992, Burns : journal of the International Society for Burn Injuries.

[50]  M. Subrahmanyam.  Topical application of honey in treatment of burns , 1991, The British journal of surgery.

[51]  P. Laughrea,et al.  [Conjunctivitis and keratitis]. , 1991, L'union medicale du Canada.

[52]  E. Germann,et al.  Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds. , 1991, Burns : journal of the International Society for Burn Injuries.

[53]  A. Supe,et al.  Formalin (0.25%) as topical anti-microbial agent in burns. , 1991, Journal of postgraduate medicine.

[54]  E. Germann,et al.  Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns. , 1991, The Journal of burn care & rehabilitation.

[55]  H. Polk,et al.  A Randomized Prospective Study of Topical Antimicrobial Agents on Skin Grafts after Thermal Injury , 1990, Plastic and reconstructive surgery.

[56]  D. Herndon,et al.  Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. , 1990, The Journal of burn care & rehabilitation.

[57]  P. D. de Wet,et al.  Bactericidal efficacy of 5 per cent povidone iodine cream in Pseudomonas aeruginosa burn wound infection. , 1990, Burns : journal of the International Society for Burn Injuries.

[58]  M. Barza.  Antibacterial agents in the treatment of ocular infections. , 1989, Infectious disease clinics of North America.

[59]  P. Thomson,et al.  Susceptibility of Pseudomonas and Staphylococcus wound isolates to topical antimicrobial agents: a 10-year review and clinical evaluation. , 1989, Burns : journal of the International Society for Burn Injuries.

[60]  D. Herndon,et al.  In vitro toxicity of topical antimicrobial agents to human fibroblasts. , 1989, The Journal of surgical research.

[61]  S. Mclinn.  Topical mupirocin vs. systemic erythromycin treatment for pyoderma , 1988, The Pediatric infectious disease journal.

[62]  D. Heimbach,et al.  Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns. , 1988, The Journal of burn care & rehabilitation.

[63]  T. Rath,et al.  Induction of hyperthyroidism in burn patients treated topically with povidone-iodine. , 1988, Burns, including thermal injury.

[64]  P. Piot,et al.  Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline , 1988, The New England journal of medicine.

[65]  M. Fisher.  Conjunctivitis in children. , 1987, Pediatric clinics of North America.

[66]  C. Holmes,et al.  A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments. , 1987, Burns, including thermal injury.

[67]  V. Velanovich,et al.  Control of burn wound sepsis: a comparison of in vitro topical antimicrobial assays. , 1987, The Journal of trauma.

[68]  J. L. Zamora.  Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. , 1986, American journal of surgery.

[69]  V. Raisys,et al.  Hyperosmolality induced by propylene glycol. A complication of silver sulfadiazine therapy. , 1985, JAMA.

[70]  D. Balogh,et al.  The influence of povidone-iodine treatment on thyroid hormones in severe burns. , 1985, The Journal of hospital infection.

[71]  P. Zellner,et al.  Povidone-iodine in the treatment of burn patients. , 1985, The Journal of hospital infection.

[72]  J. Lohr,et al.  Efficacy of topical antibiotic therapy in acute conjunctivitis in children. , 1984, The Journal of pediatrics.

[73]  A. Mason,et al.  Topical chlorhexidine diphosphanilate (WP-973) in burn wound sepsis. , 1984, Archives of surgery.

[74]  J. Lawrence,et al.  EVALUATION OF PHENOXETOL-CHLORHEXIDINE CREAM AS A PROPHYLACTIC ANTIBACTERIAL AGENT IN BURNS , 1982, The Lancet.

[75]  G. Ayliffe,et al.  Gentamicin-resistant Pseudomonas aeruginosa infection from mattresses in a burns unit. , 1981, British medical journal.

[76]  S. Modak,et al.  Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents. , 1981, Archives of surgery.

[77]  F. Hayden,et al.  Etiology of acute conjunctivitis in children. , 1981, The Journal of pediatrics.

[78]  E. Milstone,et al.  Pseudomembranous colitis after topical application of clindamycin. , 1981, Archives of dermatology.

[79]  D. Eschenbach,et al.  Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. , 1980, JAMA.

[80]  J. Leyden,et al.  Contact dermatitis to neomycin sulfate. , 1979, JAMA.

[81]  I. A. Holder,et al.  Eighteen months of routine topical antimicrobial susceptibility testing of isolates from burn patients: results and conclusions. , 1979, The Journal of antimicrobial chemotherapy.

[82]  E. Law,et al.  A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds , 1978 .

[83]  S. Modak,et al.  Topical chemotherapy for burns using cerium salts and silver sulfadiazine. , 1977, Surgery, gynecology & obstetrics.

[84]  F. Barrett,et al.  Antimicrobial Susceptibility of Group B Streptococci Isolated from a Variety of Clinical Sources , 1976, Antimicrobial Agents and Chemotherapy.

[85]  R. Yee,et al.  In Vitro Penetration of Topical Antiseptics Through Eschar of Burn Patients , 1976, Annals of surgery.

[86]  M. Finland,et al.  Susceptibility of Beta-Hemolytic Streptococci to 65 Antibacterial Agents , 1976, Antimicrobial Agents and Chemotherapy.

[87]  G. Carpenter.  Letter: Chloramphenicol eye-drops and marrow aplasia. , 1975, Lancet.

[88]  V. Beral.  Cancer of the cervix: a sexually transmitted infection? , 1974, Lancet.

[89]  J. R. Christian.  Comparison of ocular reactions with the use of silver nitrate and erythromycin ointment in ophthalmia neonatorum prophylaxis. , 1960, The Journal of pediatrics.